Investors worried about the momentum of AI capital slowing should look to healthcare and consumer staples for opportunities, according to Goldman Sachs analysts, who outlined a defensive scenario in which quality stocks could come to the fore.
The U.S. firm selected health and basic consumption stocks with lower volatility and high cash flows, while warning about the risks facing the stock market.